399 filings
Page 8 of 20
4
0yh i8904r
6 Jan 23
Cerevel Therapeutics / N ANTHONY COLES ownership change
5:04pm
8-K
koh wgtt22chup0
19 Dec 22
Cerevel Therapeutics Announces Positive Results in Emraclidine Ambulatory Blood Pressure Monitoring Trial
8:00am
4
b1wa z19pkdbgn
13 Dec 22
Cerevel Therapeutics / N ANTHONY COLES ownership change
4:44pm
EFFECT
7gfr4
21 Nov 22
Notice of effectiveness
12:15am
CORRESP
74zg2
16 Nov 22
Correspondence with SEC
12:00am
UPLOAD
jas 364jt80q9kr
10 Nov 22
Letter from SEC
12:00am
8-K
f7a95wmgfys0
8 Nov 22
Cerevel Therapeutics Reports Third Quarter 2022 Financial Results and Business Updates
6:36am
4
30s3ejj7 b63v3g
3 Nov 22
Cerevel Therapeutics / John Renger ownership change
4:28pm
4
l0r 65waa
6 Oct 22
Cerevel Therapeutics / John Renger ownership change
4:59pm
4
9ql86d9e3k ie6h
14 Sep 22
Cerevel Therapeutics / DEVAL L PATRICK ownership change
5:10pm
4
xiyan778q0i95 0s
12 Sep 22
Cerevel Therapeutics / Abraham Ceesay ownership change
4:24pm
4
8uj g314ktg9372s1jkv
24 Aug 22
Cerevel Therapeutics / Abraham Ceesay ownership change
4:05pm
4
d3av cdlq
18 Aug 22
Cerevel Therapeutics / JOSEPH EDELMAN ownership change
5:10pm
SC 13D/A
dw4eawgy85po0tuc53j
18 Aug 22
Cerevel Therapeutics / BC Perception ownership change
4:30pm
4
lj9dstrm3aaszlbxf
17 Aug 22
Cerevel Therapeutics / Abraham Ceesay ownership change
4:15pm
8-K
w2k6rx4bdquns3c56t
16 Aug 22
Entry into a Material Definitive Agreement
4:20pm
8-K
19j0thgj
12 Aug 22
Cerevel Therapeutics Announces Proposed Private Offering of Convertible Senior Notes
5:03pm
424B5
s1lp 8l2as
12 Aug 22
Prospectus supplement for primary offering
4:58pm